# 📈 Hypermagnesemia

## 🚨 EMERGENCY RECOGNITION: Hypermagnesemia

1 **Immediate Assessment:** Check deep tendon reflexes (absent \>7-10 mg/dL), respiratory effort, cardiac rhythm 2 **Life-threatening Signs:** Respiratory depression, complete heart block, cardiac arrest risk 3 **Immediate Treatment:** IV calcium (1-2g calcium chloride or 2-3g calcium gluconate) for functional antagonism 4 **Definitive Management:** Support unstable physiology; consider renal elimination only with adequate kidney function and fluid tolerance, or dialysis for severe toxicity/poor clearance

## 📊 Definition and Clinical Significance

### Hypermagnesemia Definition

- **Serum Magnesium:** \>2.6 mg/dL (1.1 mmol/L)
- **Mild:** 2.6-4.8 mg/dL (1.1-2.0 mmol/L)
- **Moderate:** 4.8-10.8 mg/dL (2.0-4.5 mmol/L)
- **Severe:** \>10.8 mg/dL (\>4.5 mmol/L)
- **Life-threatening:** \>15.6 mg/dL (\>6.5 mmol/L)

## 🎯 Causes of Hypermagnesemia

### Renal Impairment (Primary Risk)

- **CKD stages 4-5:** eGFR \<30 mL/min/1.73m²
- **Acute kidney injury:** Oliguria, volume overload
- **ESRD patients:** Between dialysis sessions
- **Key Point:** Rare in normal renal function

### Exogenous Administration

- **IV magnesium overdose:** Eclampsia treatment errors
- **Mg-containing antacids:** Chronic use in CKD
- **Mg-containing laxatives:** Cathartic abuse
- **Epsom salt ingestion:** Therapeutic or suicidal

### Endocrine Disorders

- **Primary hyperparathyroidism:** Bone resorption
- **Hypothyroidism:** Reduced renal clearance
- **Addison's disease:** Volume depletion
- **Lithium toxicity:** Altered renal handling

### Other Conditions

- **Massive tissue necrosis:** Rhabdomyolysis
- **Tumor lysis syndrome:** Rapid cell breakdown
- **Familial hypocalciuric hypercalcemia:** Genetic
- **Milk-alkali syndrome:** Calcium carbonate excess

## 🔍 Clinical Manifestations by Severity

| Mg Level (mg/dL) | Mg Level (mmol/L) | Clinical Manifestations | Management Priority |
|----|----|----|----|
| 4.8-6.0 | 2.0-2.5 | Asymptomatic, mild sedation | Monitor, review sources |
| 6.0-10.8 | 2.5-4.5 | Absent DTRs, weakness, confusion | Active treatment required |
| 10.8-15.6 | 4.5-6.5 | Respiratory depression, complete heart block | ICU monitoring, urgent treatment |
| \>15.6 | \>6.5 | Cardiac arrest, coma | Emergency intervention |

### 🧮 Hypermagnesemia Risk Calculator

Serum Creatinine (mg/dL): 1.0 Current Mg Level (mg/dL): 3.0 Magnesium-containing medications\
CKD Stage 4-5\
Recent IV Mg administration **Risk Assessment:** Enter values to calculate risk

## 🔬 Diagnostic Workup

### Initial Laboratory Assessment

- **Serum magnesium (fasting):** \>2.6 mg/dL diagnostic
- **Basic metabolic panel:** Renal function assessment
- **Serum creatinine, eGFR:** Magnesium clearance capacity
- **Serum calcium:** Rule out concurrent hypercalcemia

### Cardiac Assessment

- **12-lead ECG:** PR prolongation, QRS widening
- **Continuous monitoring:** Arrhythmia detection
- **Echocardiogram:** Severe cases, cardiac function
- **Hemodynamic monitoring:** Blood pressure trends

### Neurologic Assessment

- **Deep tendon reflexes:** Absent \>7-10 mg/dL
- **Mental status exam:** Confusion progression
- **Respiratory assessment:** Muscle weakness
- **Arterial blood gas:** If respiratory depression

### Exposure History

- **Medication review:** Antacids, laxatives, IV supplements
- **Recent procedures:** Bowel prep, therapeutic interventions
- **Ingestion history:** Epsom salts, remedies
- **Additional testing:** PTH, TSH, lithium level

## 💊 Treatment Strategies

### Severe Symptomatic Hypermagnesemia (\>7 mg/dL)

1 **Immediate IV Calcium:** 1-2g calcium chloride OR 2-3g calcium gluconate in 50-100 mL NS over 5-10 minutes 2 **Mechanism:** Functional antagonism at neuromuscular junctions and cardiac conduction system 3 **Duration:** Effects within minutes but temporary - may need repeated dosing 4 **Monitoring:** Continuous cardiac monitoring, neurologic checks q15min

### Enhanced Elimination

- **Renal elimination:** A monitored fluid/loop-diuretic strategy may be appropriate when kidney function and volume tolerance permit. Do not force saline in anuric or congested patients; assess dialysis for severe toxicity with poor clearance.
- **Mechanism:** Increases renal magnesium clearance
- **Monitoring:** I/O balance, electrolytes q4-6h
- **Contraindication:** Severe renal failure

### Hemodialysis Indications

- **Severe hypermagnesemia + renal failure**
- **Hemodynamic instability**
- **Respiratory failure**
- **Clearance:** ~100 mL/min standard HD

### Supportive Care

- **Respiratory support:** Mechanical ventilation PRN
- **Hemodynamic support:** Vasopressors for hypotension
- **Cardiac monitoring:** Conduction abnormalities
- **Neurologic monitoring:** Serial reflex assessments

## ⚠️ Special Clinical Considerations

### Magnesium-Containing Laxatives in CKD

- **High-Risk Populations:** CKD stages 4-5 (eGFR \<30 mL/min/1.73m²)
- **Dangerous Formulations:** Mg sulfate (Epsom salt), Mg hydroxide (milk of magnesia), Mg citrate
- **Single Dose Risk:** Mg citrate contains ~1.75g elemental magnesium
- **Monitoring:** Baseline and 24-48h follow-up Mg levels required
- **Alternatives:** PEG-based laxatives (MiraLAX), docusate sodium, stimulant laxatives

### ECG Changes in Hypermagnesemia

- **Early changes:** PR interval prolongation
- **Progressive:** QRS widening, peaked T waves
- **Severe:** Complete heart block, asystole
- **Mimics:** Hyperkalemia ECG changes

### Drug Interactions

- **Neuromuscular blocking agents:** Prolonged paralysis
- **Calcium channel blockers:** Enhanced hypotensive effects
- **Digoxin:** Reduced toxicity risk
- **Aminoglycosides:** Enhanced nephrotoxicity

## 🛡️ Prevention and Risk Mitigation

### High-Risk Patient Identification

- **CKD patients:** Stages 4-5, regular monitoring
- **Elderly patients:** Reduced renal function, medications
- **ICU patients:** Multiple medications, renal dysfunction
- **Post-surgical:** Bowel prep complications

### Medication Safety

- **Renal dosing:** Adjust all Mg-containing medications
- **Patient education:** OTC antacid/laxative risks
- **Pharmacy alerts:** CKD contraindications
- **Alternative agents:** Safer options in renal dysfunction

### Monitoring Protocols

- **Baseline assessment:** All high-risk patients
- **Serial monitoring:** Q2-4h during treatment
- **Clinical correlation:** Symptoms vs. lab values
- **Long-term follow-up:** Prevent recurrence

## 🎯 Key Learning Points

- **Recognition:** Hypermagnesemia rarely occurs with normal renal function - always suspect in CKD patients
- **Clinical Assessment:** Absent deep tendon reflexes at \>7-10 mg/dL provide reliable early warning
- **Emergency Treatment:** IV calcium provides immediate functional antagonism while definitive therapy initiated
- **Dialysis Indication:** Emergency dialysis required for severe hypermagnesemia with renal failure
- **Prevention:** Avoid magnesium-containing laxatives/antacids in CKD stages 4-5 patients
- **Monitoring:** Serial neurologic assessments more reliable than serum levels alone for treatment response
- **Drug Safety:** All magnesium-containing medications require renal dosing adjustments
- **Prognosis:** Good outcomes with early recognition and appropriate management


---

[Website version](https://urinenephrology.org/2025_UDPA_Lectures_Live/electrolytes/magnesium/hypermagnesemia.html) · Markdown synchronized October 3, 2026.